Exclusion Criteria
Subjects who are receiving primary prophylaxis
boolean
Subjects on prophylaxis with documented requirements of > 75 IU/kg/week
boolean
Subjects with any other bleeding disease beside hemophilia A (i.e., von Willebrand disease)
boolean
Subjects with abnormal renal function
boolean
Subjects with elevated hepatic transaminases
boolean
Subjects on treatment with immunomodulatory agents within the last 3 months prior to study entry or during the study
boolean
Subjects with known hypersensitivity to the active substance, mouse or hamster protein, liposomes or polyethyleneglycol (PEG)
boolean
Subjects who require any pre-medication for FVIII injections
boolean